Abstract: Apparatuses, systems, and methods are disclosed for subcutaneous transcranial functional ultrasound technique. An example apparatus includes a substrate and a device configured to be disposed under skin. The device includes one or more transducers disposed on the substrate and provides a pressure wave that propagates a body part under the skin. The pressure wave has a fundamental frequency within a range approximately from 10 Hz to 10 GHz.

Abstract: Apparatuses, systems, and methods are disclosed for subcutaneous functional near-infrared spectroscopy. An example apparatus includes a substrate and a device configured to be disposed under skin. The device includes emitters and light detectors disposed on the substrate. The emitters emit light that propagates a body part under skin and the light detectors detect changes in light absorption and scattering through the body part and provide fNIRS signals.

Abstract: According to some embodiments, systems and methods are provided including a memory storing program code to: execute a functional automation tool for an application under test in at least two languages, wherein execution of the functional automation tool includes a rendering of a plurality of user interfaces in each of the at least two languages; identify at least one of a label and a tooltip in each of the plurality of user interfaces; capture a screenshot for each of the plurality of user interfaces, wherein the captured screenshots include a first screenshot and at least one subsequent screenshot; identify the subsequent screenshot as unique or redundant; and render a language acceptance testing output for each unique screenshot, displaying each identified label and tooltip in the at least two languages. Numerous other aspects are provided.

Abstract: The present disclosure generally relates to auditory nerve stimulation to create the perception of sound in the brain of a subject such as an animal or human being. In one form, a system includes an implantable electrode array including a plurality of spaced apart micro-needles. The system also includes a first electrical lead electrically coupled to and extending from the implantable electrode array, and an auditory signal device configured to produce one or more electrical signals representative of communications received from an external processor. An interposer is configured to electrically couple the implantable electrode array and the auditory signal device in an arrangement where one or more electrical signals produced by the auditory signal device may be transmitted through the first electrical lead to the implantable electrode array. Various novel stimulation strategies can be employed, such as place modulated stimulation signals.

Abstract: The present disclosure provides systems and methods related to electroencephalography (EEG) electrode arrays. In particular, the present disclosure provides systems and methods relating to the manufacture and use of high-resolution electrocorticography (ECOG) electrode arrays and stereoelectroencephalography (SEEG) electrode arrays having various combinations and arrangements of microelectrodes and macroelectrodes for recording and modulating nervous system activity.

Abstract: A method of manufacturing a micro-molded electrode having multiple individually addressable sensors along a shaft can include forming a recess in a mold substrate, depositing a structural material therein, depositing a conductive material at specific locations, providing a coating, and removing the mold substrate. A micro-molded electrode having a base tapering to at least one shaft can include an electrode substrate, multiple individually addressable sensors, and a coating.

Abstract: A method of manufacturing a micro-molded electrode (160) having multiple individually addressable sensors (140) along a shaft (180) can include forming a recess in a mold substrate, depositing a structural material therein, depositing a conductive material at specific locations, providing a coating (190), and removing the mold substrate. A micro-molded electrode (160) having a base (170) tapering to at least one shaft (180) can include an electrode substrate, multiple individually addressable sensors (140), and a coating (190).

Abstract: A multi-site electrode array (100) can include a microneedle array and a set of electrically active sites (115). The microneedle array includes a plurality of microneedles (105) supported on a base substrate (110). The set of electrically active sites (115) can be arranged at and/or near the tip of each microneedle (105), and in many cases along a shaft of the microneedles. Further, at least a portion of the active sites (115) can be independently electrically addressable such that a remaining portion of the active sites (115) are optionally electrically shunted together. In some cases all of the active sites (115) are independently electrically addressable.

Abstract: An implantable medical device can include an electrode substrate electrically connected to at least one electrode. The device can have a pseudoporous surface across the electrode substrate and electrode. This surface can result in a real surface area (RSA) greater than the geometric surface area (GSA) of the device. The pseudoporous surface can be a macroporous surface enabling a charge injection capacity greater than 1 mC/cm2 while minimizing rejection of the device by surrounding tissue in chronic implant applications. The electrode can be a thin layer of conductive material, such as platinum or another metal, conformally deposited on the pseudoporous surface of the electrode substrate. A method of making the implantable device can include forming the device having an electrode substrate and at least one electrode electrically coupled to the electrode substrate, and forming a pseudoporous surface on the electrode substrate and electrode.

Abstract: A high aspect ratio shadow mask and a method of making and using the high aspect ratio shadow mask can provide multiple conductive trace pathways along high aspect ratio electrodes. The high aspect ratio shadow mask can include a substantially planar base layer and a plurality of hollow high aspect ratio projections extending from the substantially planar base layer. The high aspect ratio shadow mask can further include a plurality of openings along the hollow projections which define trace deposition patterns.

Abstract: Technology for a neural interface is described. The neural interface can include an intracranial electrode grid operable to detect neural activity. The neural interface can include a subcutaneous microelectronic signal processing unit operable to process the neural activity in order to obtain digital neural activity information. The neural interface can include a cable connecting the intracranial electrode grid and the subcutaneous microelectronic signal processing unit. The neural interface can include a wired connector attached to the subcutaneous microelectronic signal processing unit that is operable to transmit the digital neural activity information from the subcutaneous microelectronic signal processing unit to an external signal processing device.

Abstract: The invention relates to a catalyst composition suitable for the non-oxidative dehydrogenation of alkanes having 2-8 carbon atoms comprising silico-zinc aluminate, wherein the relative molar ratios of the elements comprised in said composition are represented by SixZn1-xAl2O4, wherein x stands for a number in the range from 0.003 to 0.76. The invention also relates to a process for the preparation of said catalyst composition, to a process for the non-oxidative dehydrogenation of alkanes, preferably isobutane using said catalyst and to the use of said catalyst in a process for the non-oxidative dehydrogenation of alkanes.

Abstract: A high aspect ratio shadow mask and a method of making and using the high aspect ratio shadow mask can provide multiple conductive trace pathways along high aspect ratio electrodes. The high aspect ratio shadow mask can include a substantially planar base layer and a plurality of hollow high aspect ratio projections extending from the substantially planar base layer. The high aspect ratio shadow mask can further include a plurality of openings along the hollow projections which define trace deposition patterns.

Abstract: A multi-site electrode array (100) can include a microneedle array and a set of electrically active sites (115). The microneedle array includes a plurality of microneedles (105) supported on a base substrate (110). The set of electrically active sites (115) can be arranged at and/or near the tip of each microneedle (105), and in many cases along a shaft of the microneedles. Further, at least a portion of the active sites (115) can be independently electrically addressable such that a remaining portion of the active sites (115) are optionally electrically shunted together.

Abstract: A method of manufacturing a micro-molded electrode (160) having multiple individually addressable sensors (140) along a shaft (180) can include forming a recess in a mold substrate, depositing a structural material therein, depositing a conductive material at specific locations, providing a coating (190), and removing the mold substrate. A micro-molded electrode (160) having a base (170) tapering to at least one shaft (180) can include an electrode substrate, multiple individually addressable sensors (140), and a coating (190).

Abstract: An implantable medical device can include an electrode substrate electrically connected to at least one electrode. The device can have a pseudoporous surface across the electrode substrate and electrode. This surface can result in a real surface area (RSA) greater than the geometric surface area (GSA) of the device. The pseudoporous surface can be a macroporous surface enabling a charge injection capacity greater than 1 mC/cm2 while minimizing rejection of the device by surrounding tissue in chronic implant applications. The electrode can be a thin layer of conductive material, such as platinum or another metal, conformally deposited on the pseudoporous surface of the electrode substrate. A method of making the implantable device can include forming the device having an electrode substrate and at least one electrode electrically coupled to the electrode substrate, and forming a pseudoporous surface on the electrode substrate and electrode.

Abstract: Technology for a neural interface is described. The neural interface can include an intracranial electrode grid operable to detect neural activity. The neural interface can include a subcutaneous microelectronic signal processing unit operable to process the neural activity in order to obtain digital neural activity information. The neural interface can include a cable connecting the intracranial electrode grid and the subcutaneous microelectronic signal processing unit. The neural interface can include a wired connector attached to the subcutaneous microelectronic signal processing unit that is operable to transmit the digital neural activity information from the subcutaneous microelectronic signal processing unit to an external signal processing device.

Abstract: A micro-needle array having tips disposed along a non-planar surface is formed by shaping the wafer surface into a non-planar surface to define the tips of the micro-needles. A plurality of trenches are cut into the wafer to form a plurality of columns having tops corresponding to the non-planar surface. The columns are rounded and sharpened by etching to form the micro-needles.

Abstract: The invention relates to a catalyst composition suitable for the non-oxidative dehydrogenation of alkanes having 2-8 carbon atoms comprising silico-zinc aluminate, wherein the relative molar ratios of the elements comprised in said composition are represented by SixZn1-xAl2O4, wherein x stands for a number in the range from 0.003 to 0.76. The invention also relates to a process for the preparation of said catalyst composition, to a process for the non-oxidative dehydrogenation of alkanes, preferably isobutane using said catalyst and to the use of said catalyst in a process for the non-oxidative dehydrogenation of alkanes.

Abstract: Methods for wafer-scale fabrication of needle arrays can include mechanically modifying a wafer to produce a plurality of vertically-extending columns. The columns are etched to round and reshape the columns into substantially uniformly shaped needles. Needle arrays having needle width non-uniformity of less than about 3% and length non-uniformity of less than about 2% can be produced.